Alpha-9 Oncology - Crunchbase Company Profile & Funding

Q: Who invested in Alpha-9 Oncology?

Alpha-9 Oncology has 18 investors including Samsara BioCapital And Lumira Ventures.

Q: When was the last funding round for Alpha-9 Oncology?

Alpha-9 Oncology closed its last funding round on obfuscated from a Series C round.

Q: How much funding has Alpha-9 Oncology raised to date?

Alpha-9 Oncology has raised obfuscated.

Overview

Alpha-9 Oncology

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Alpha-9 Oncology

CB Rank

22994

Alpha-9 Oncology is a biopharma company that focuses on radiotherapeutics for the treatment of solid and hematologic malignancies.

Founded

obfuscation

Private

Series C

Vancouver, British Columbia, Canada

51-100

www.a9oncology.com

Biotechnology

Medical

Product Research

Funding Rounds

Series C

OBF

obfuscation

Series B

OBF

obfuscation

Series A

OBF

obfuscation

Key People

Paul Blanchfield: Chief Executive Officer
Past Role: Lantheus Holdings, President
Ian McBeath: CEO

Details

Legal Name

Alpha-9 Oncology, Inc.

Also Known As

Alpha 9 Theranostics

Operating Status

Active

Company Type

For Profit

Founders

David Perrin

Phone Number

+1 778-231-2500

Contact Email

imcb@alpha9tx.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Key Employee Changes

Products & Services

Engineered molecules

Alpha9 Theranostics develops radiotherapeutic molecules for treating solid and hematologic malignancies, utilizing a toolbox of technologies for peptide-based radiopharmaceuticals.

Radiopharmaceuticals

Radiopharmaceuticals by Alpha9 Theranostics are designed for selective radiation delivery to cancer cells, comprising binders, linkers, chelators, and radioisotopes for optimal selectivity and stability.

Research & Development

Alpha-9 Oncology is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series C - Alpha-9 Oncology	16	obfuscated obfuscation	Ascenta Capital, Lightspeed Venture Partners	Series C
obfuscated obfuscation	Series C - Alpha-9 Oncology	16	obfuscated obfuscation	Ascenta Capital, Lightspeed Venture Partners	Series C
obfuscated obfuscation	Series C - Alpha-9 Oncology	16	obfuscated obfuscation	Ascenta Capital, Lightspeed Venture Partners	Series C
obfuscated obfuscation	Series C - Alpha-9 Oncology	16	obfuscated obfuscation	Ascenta Capital, Lightspeed Venture Partners	Series C
obfuscated obfuscation	Series C - Alpha-9 Oncology	16	obfuscated obfuscation	Ascenta Capital, Lightspeed Venture Partners	Series C

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series C - Alpha-9 Oncology	16	obfuscated obfuscation	Ascenta Capital, Lightspeed Venture Partners	Series C
obfuscated obfuscation	Series C - Alpha-9 Oncology	16	obfuscated obfuscation	Ascenta Capital, Lightspeed Venture Partners	Series C
obfuscated obfuscation	Series C - Alpha-9 Oncology	16	obfuscated obfuscation	Ascenta Capital, Lightspeed Venture Partners	Series C
obfuscated obfuscation	Series C - Alpha-9 Oncology	16	obfuscated obfuscation	Ascenta Capital, Lightspeed Venture Partners	Series C
obfuscated obfuscation	Series C - Alpha-9 Oncology	16	obfuscated obfuscation	Ascenta Capital, Lightspeed Venture Partners	Series C

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Samsara BioCapital	—	Series C - Alpha-9 Oncology	Cory Freedland
Samsara BioCapital	—	Series C - Alpha-9 Oncology	Cory Freedland
Samsara BioCapital	—	Series C - Alpha-9 Oncology	Cory Freedland
Samsara BioCapital	—	Series C - Alpha-9 Oncology	Cory Freedland
Samsara BioCapital	—	Series C - Alpha-9 Oncology	Cory Freedland